Nuvectis Pharma, Inc. (NVCT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 164.69M |
| Enterprise Value | 133.05M |
| P/E Ratio | -17.98 |
| PEG Ratio | 1.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 60.9 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -20.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.24 |
| Return On Equity | -1.69 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -26.44M |
| Net Income | -26.44M |
| Diluted EPS | -1.32 |
| Total Cash | 22.16M |
| Total Cash/Share | 0.94 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.68 |
| Book Value Per Share | 0.39 |
| 52-Week Change | 242.94 |
| 52-Week High | 29.28 |
| 52-Week Low | 5.55 |
| Moving Average 50 Days | 19.29 |
| Moving Average 200 Days | 11.09 |
| Average Volume | 314,945 |
| Shares Outstanding | 26.54M |
| % Held by Institutions | 19.3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |